Thermo Fisher Scientific | TMO - Current Liabilities



Thermo Fisher Scientific reported $12.72B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Abbott USD 13.44B 435M Jun/2025
Agilent USD 1.89B 120M Jul/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Bio Techne USD 175.85M 6.64M Jun/2025
Bio-Rad Laboratories USD 548.9M 42.3M Jun/2025
Boston Scientific USD 5.06B 1.34B Mar/2025
Bruker USD 1.35B 2.5M Jun/2025
Charles River Laboratories USD 1.08B 29.38M Jun/2025
Danaher USD 6.79B 147M Jun/2025
Dentsply International USD 1.17B 627M Jun/2025
Edwards Lifesciences USD 1.39B 110.4M Mar/2025
Exact Sciences USD 521.93M 19.47M Jun/2025
General Electric Aerospace USD 36.47B 1.52B Jun/2025
Henry Schein USD 3.01B 90M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Illumina USD 1.46B 21M Jun/2025
Intuitive Surgical USD 2.21B 197.4M Jun/2025
IQVIA Holdings USD 7.57B 393M Jun/2025
Laboratory Of America USD 2.72B 652.2M Jun/2025
Medtronic USD 12.88B 1.04B Apr/2025
Mettler Toledo International USD 1.11B 42.8M Jun/2025
Myriad Genetics USD 151.1M 13M Mar/2025
Olympus JPY 351.93B 73.43B Jun/2025
Quest Diagnostics USD 2.02B 583M Jun/2025
Repligen USD 152M 25.21M Mar/2025
Revvity USD 671.81M 23.63M Jun/2025
Stryker USD 7.29B 641M Jun/2025
Thermo Fisher Scientific USD 12.72B 456M Jun/2025
Veracyte USD 76.43M 1.31M Jun/2025
Waters USD 1.02B 55.16M Jun/2025
Zimmer Biomet Holdings USD 2.7B 404.6M Jun/2025